Boycott threat forces French company to abandon RU486
BMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7088.1145m (Published 19 April 1997) Cite this as: BMJ 1997;314:1145- Alexander Dorozynski
- Paris
Pressure by American antiabortion activists has led the French pharmaceutical company Roussel-Uclaf, subsidiary of the German company Hoechst, to abandon production and distribution of mifepristone (RU486), the “abortion pill.”
The company has transferred all patent rights, without charge, to Dr Edouard Sarkiz, one of the pill's developers, who hopes to develop its potential in other therapeutic areas.
Antiabortionists had long threatened to boycott Hoechst and Roussel-Uclaf's products in the United States if the pill was marketed there. A few months ago, Hoechst acquired all shares of Marion …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.